153
Views
0
CrossRef citations to date
0
Altmetric
Review Articles

Elements in trace amount with a significant role in human physiology: a tumor pathophysiological and diagnostic aspects

ORCID Icon, , , &
Pages 270-286 | Received 12 Sep 2023, Accepted 09 Jan 2024, Published online: 01 Feb 2024

References

  • Jahankhani K, Ahangari F, Adcock IM, et al. Possible cancer-causing capacity of COVID-19: is SARS-CoV-2 an oncogenic agent? Biochimie. 2023;213:130–138. doi: 10.1016/j.biochi.2023.05.014.
  • Jahankhani K, Taghipour N, Mashhadi Rafiee M, et al. Therapeutic effect of trace elements on multiple myeloma and mechanisms of cancer process. Food Chem Toxicol. 2023;179:113983. doi: 10.1016/j.fct.2023.113983.
  • Underwood C, van Eps AW. Nanomedicine and veterinary science: the reality and the practicality. Vet J. 2012;193(1):12–23. doi: 10.1016/j.tvjl.2012.01.002.
  • Bhattacharya PT, Misra SR, Hussain M. Nutritional aspects of essential trace elements in oral health and disease: an extensive review. Scientifica. 2016;2016:5464373. doi: 10.1155/2016/5464373.
  • Hossain KG, Islam N, Ghavami F, et al. Effect of increased amounts of Fe, Zn, and cd on uptake, translocation, and accumulation of human health related micronutrients in wheat. Asian J Agric Food Sci. 2017;5(1):19–29.
  • Bray F, Laversanne M, Weiderpass E, et al. The ever-increasing importance of cancer as a leading cause of premature death worldwide. Cancer. 2021;127(16):3029–3030. doi: 10.1002/cncr.33587.
  • Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi: 10.3322/caac.21660.
  • World Health Organization (WHO). Deaths by cause, age, sex, by country and by region. In: Global health estimates; 2020. Availble from https://www.who.int/news-room/fact-sheets/detail/cancer#:∼:text=The%20problem-,Cancer%20is%20a%20leading%20cause%20of%20death%20worldwide%2C%20accounting%20for,deaths%20in%202020%20(1).
  • Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55(2):74–108. doi: 10.3322/canjclin.55.2.74.
  • Callejón-Leblic B, Rodríguez-Moro G, Arias-Borrego A, et al. Absolute quantification of selenoproteins and selenometabolites in lung cancer human serum by column switching coupled to triple quadrupole inductively coupled plasma mass spectrometry. J Chromatogr A. 2020;1619:460919. doi: 10.1016/j.chroma.2020.460919.
  • Prasad AS. Zinc: an overview. Nutrition. 1995;11(1 Suppl):93–99.
  • Turski ML, Thiele DJ. New roles for copper metabolism in cell proliferation, signaling, and disease. J Biol Chem. 2009;284(2):717–721. doi: 10.1074/jbc.R800055200.
  • Torti SV, Torti FM. Iron and cancer: more ore to be mined. Nat Rev Cancer. 2013;13(5):342–355. doi: 10.1038/nrc3495.
  • Costello LC, Franklin RB. A comprehensive review of the role of zinc in normal prostate function and metabolism; and its implications in prostate cancer. Arch Biochem Biophys. 2016;611:100–112. doi: 10.1016/j.abb.2016.04.014.
  • Popescu E, Stanescu AMA. Trace elements and cancer. Rev Med Mod. 2019;26(4):169–175. doi: 10.31689/rmm.2019.26.4.169.
  • Prashanth L, Kattapagari K, Chitturi R, et al. A review on role of essential trace elements in health and disease. J NTR Univ Health Sci. 2015;4(2):75–85. doi: 10.4103/2277-8632.158577.
  • Wada O. What are trace elements? Their deficiency and excess states. JMAK. 2004;47.
  • Zofkova I, Davis M, Blahos J. Trace elements have beneficial, as well as detrimental effects on bone homeostasis. Physiol Res. 2017;66(3):391–402. doi: 10.33549/physiolres.933454.
  • Kim N, Lee HJ. Redox-active metal ions and amyloid-degrading enzymes in Alzheimer’s disease. Int J Mol Sci. 2021;22(14):7697. doi: 10.3390/ijms22147697.
  • Abbaspour N, Hurrell R, Kelishadi R. Review on iron and its importance for human health. J Res Med Sci. 2014;19(2):164–174.
  • Peters U, Chatterjee N, Church TR, et al. High serum selenium and reduced risk of advanced colorectal adenoma in a colorectal cancer early detection program. Cancer Epidemiol Biomarkers Prev. 2006;15(2):315–320. doi: 10.1158/1055-9965.epi-05-0471.
  • Rizk SL, Sky-Peck HH. Comparison between concentrations of trace elements in normal and neoplastic human breast tissue. Cancer Res. 1984;44(11):5390–5394.
  • Dawood SD. A study of serum zinc, iron, selenium, and copper levels in patients with bladder cancer. Iraqi J Cancer Med. 2018. https://api.semanticscholar.org/CorpusID:211117342.
  • Fadhil HY, Aufi IM, Aboud RS, et al. Effect of oral zinc sulfate on local inflammatory cytokines level in Iraqi women infected with human papillomavirus (HPV). IOSR J Pharm Biol Sci. 2017;12(3):14–17. doi: 10.9790/3008-1203011417.
  • Wang CT, Chang WT, Yang TL. Study of the concentrations of calcium, copper, iron, magnesium and zinc in the hair of breast cancer patients. Trace Element Electrolytes. 2006;23(10):281–286. doi: 10.5414/TEP23281.
  • Navarro Silvera SA, Rohan TE. Trace elements and cancer risk: a review of the epidemiologic evidence. Cancer Causes Control. 2007;18(1):7–27. doi: 10.1007/s10552-006-0057-z.
  • Jain AK, Mishra A, Singh AP, et al. Effects of different concentration of organic and inorganic trace minerals (zinc, selenium, and chromium) supplementation on expression of chTLR4 gene and humoral immune response in broilers. Vet World. 2021;14(5):1093–1101. doi: 10.14202/vetworld.2021.1093-1101.
  • Janiszewski LN, Minson M, Allen MA, et al. Characterization of global gene expression, regulation of metal ions, and infection outcomes in immune-competent 129S6 mouse macrophages. Infect Immun. 2021;89(11):e0027321. doi: 10.1128/iai.00273-21.
  • Sgarbieri UR, Fisberg M, Tone LG, et al. Nutritional assessment and serum zinc and copper concentration among children with acute lymphocytic leukemia: a longitudinal study. Sao Paulo Med J. 2006;124(6):316–320. doi: 10.1590/s1516-31802006000600003.
  • Alkufi HA. Determination the levels of zinc and copper in patients with leukemia. Int J Curr Microbiol Appl Sci. 2015;4:812–816.
  • Mehrzad V, Mahmood-Zadeh M, Feizi A, et al. Determination relation of the zinc serum level in acute leukemia adult patients with mucositis and neutropenic prevalence before and after treatment in Isfahan’ Seyed-Al-Shohada hospital, 2012–2013. Adv Biomed Res. 2018;7:31. doi: 10.4103/abr.abr_7_15.
  • Wiemels J. New insights into childhood leukemia etiology. Eur J Epidemiol. 2015;30(12):1225–1227. doi: 10.1007/s10654-015-0115-5.
  • Gundogdu M, Kaya H, Gulcin I, et al. Oxidase activity of ceruloplasmin and some acute phase reactant and trace element concentrations in serum of patients with chronic lymphocytic leukemia. Scott Med J. 2007;52(1):24–27. doi: 10.1258/rsmsmj.52.1.24.
  • Wiernsperger N, Rapin J. Trace elements in glucometabolic disorders: an update. Diabetol Metab Syndr. 2010;2(1):70. doi: 10.1186/1758-5996-2-70.
  • Azin F, Raie RM, Mahmoudi MM. Correlation between the levels of certain carcinogenic and anticarcinogenic trace elements and esophageal cancer in Northern Iran. Ecotoxicol Environ Saf. 1998;39(3):179–184. doi: 10.1006/eesa.1997.1601.
  • Dubey P, Thakur V, Chattopadhyay M. Role of minerals and trace elements in diabetes and insulin resistance. Nutrients. 2020;12(6):1864. doi: 10.3390/nu12061864.
  • Guidotti TL, McNamara J, Moses MS. The interpretation of trace element analysis in body fluids. Indian J Med Res. 2008;128(4):524–532.
  • Cui Y, Vogt S, Olson N, et al. Levels of zinc, selenium, calcium, and iron in benign breast tissue and risk of subsequent breast cancer. Cancer Epidemiol Biomarkers Prev. 2007;16(8):1682–1685. doi: 10.1158/1055-9965.epi-07-0187.
  • Yelinova V, Glazachev Y, Khramtsov V, et al. Studies of human and rat blood under oxidative stress: changes in plasma thiol level, antioxidant enzyme activity, protein carbonyl content, and fluidity of erythrocyte membrane. Biochem Biophys Res Commun. 1996;221(2):300–303. doi: 10.1006/bbrc.1996.0590.
  • Lee MR, Lim YH, Lee BE, et al. Blood mercury concentrations are associated with decline in liver function in an elderly population: a panel study. Environ Health. 2017;16(1):17. doi: 10.1186/s12940-017-0228-2.
  • Zhang C, Gan C, Ding L, et al. Maternal inorganic mercury exposure and renal effects in the Wanshan mercury mining area, southwest China. Ecotoxicol Environ Saf. 2020;189:109987. doi: 10.1016/j.ecoenv.2019.109987.
  • Tapiero H, Townsend DM, Tew KD. Trace elements in human physiology and pathology. Copper. Biomed Pharmacother. 2003;57(9):386–398. doi: 10.1016/s0753-3322(03)00012-x.
  • Kambe T, Taylor KM, Fu D. Zinc transporters and their functional integration in mammalian cells. J Biol Chem. 2021;296:100320. doi: 10.1016/j.jbc.2021.100320.
  • Pedrinelli V, Zafalon RVA, Rodrigues RBA, et al. Concentrations of macronutrients, minerals and heavy metals in home-prepared diets for adult dogs and cats. Sci Rep. 2019;9(1):13058. doi: 10.1038/s41598-019-49087-z.
  • Mabate TP, Maqunga NP, Ntshibongo S, et al. Metal oxides and their roles in heterogeneous catalysis: special emphasis on synthesis protocols, intrinsic properties, and their influence in transfer hydrogenation reactions. SN Appl Sci. 2023;5(7):196. doi: 10.1007/s42452-023-05416-6.
  • Singh R, Gautam N, Mishra A, et al. Heavy metals and living systems: an overview. Indian J Pharmacol. 2011;43(3):246–253. doi: 10.4103/0253-7613.81505.
  • Gencheva R, Cheng Q, Arnér ESJ. Thioredoxin reductase selenoproteins from different organisms as potential drug targets for treatment of human diseases. Free Radic Biol Med. 2022;190:320–338. doi: 10.1016/j.freeradbiomed.2022.07.020.
  • Hariharan S, Dharmaraj S. Selenium and selenoproteins: it’s role in regulation of inflammation. Inflammopharmacology. 2020;28(3):667–695. doi: 10.1007/s10787-020-00690-x.
  • Minich WB. Selenium metabolism and biosynthesis of selenoproteins in the human body. Biochemistry. 2022;87(Suppl 1):S168–S102. doi: 10.1134/s0006297922140139.
  • Krężel A, Maret W. The bioinorganic chemistry of mammalian metallothioneins. Chem Rev. 2021;121(23):14594–14648. doi: 10.1021/acs.chemrev.1c00371.
  • Lin PH, Sermersheim M, Li H, et al. Zinc in wound healing modulation. Nutrients. 2017;10(1):16. doi: 10.3390/nu10010016.
  • Stehle P, Stoffel-Wagner B, Kuhn KS. Parenteral trace element provision: recent clinical research and practical conclusions. Eur J Clin Nutr. 2016;70(8):886–893. doi: 10.1038/ejcn.2016.53.
  • Wazir SM, Ghobrial I. Copper deficiency, a new triad: anemia, leucopenia, and myeloneuropathy. J Community Hosp Intern Med Perspect. 2017;7(4):265–268. doi: 10.1080/20009666.2017.1351289.
  • Havel PJ. A scientific review: the role of chromium in insulin resistance. Diabetes Educ. 2004;Suppl:2–14.
  • Lipko M, Debski B. Mechanism of insulin-like effect of chromium(III) ions on glucose uptake in C2C12 mouse myotubes involves ROS formation. J Trace Elem Med Biol. 2018;45:171–175. doi: 10.1016/j.jtemb.2017.10.012.
  • Reyes-López M, Aguirre-Armenta B, Piña-Vázquez C, et al. Hemoglobin uptake and utilization by human protozoan parasites: a review. Front Cell Infect Microbiol. 2023;13:1150054. doi: 10.3389/fcimb.2023.1150054.
  • Mullur R, Liu YY, Brent GA. Thyroid hormone regulation of metabolism. Physiol Rev. 2014;94(2):355–382. doi: 10.1152/physrev.00030.2013.
  • Disturbances of free water, electrolytes, acid-base balance, and oncotic pressure. Vet Med. 2017:113–152. doi: 10.1016/B978-0-7020-5246-0.00005-X.
  • Agarwal V, Jindal D, Agarwal S, et al. Initiation of neurodegenerative disorders (NDDs) through metal toxicity generated oxidative stress. In: Kesari KK, Jha NK, editors. Free radical biology and environmental toxicity. Cham: Springer International Publishing; 2021. p. 263–277.
  • Meng Y, Sun J, Yu J, et al. Dietary intakes of calcium, iron, magnesium, and potassium elements and the risk of colorectal cancer: a meta-analysis. Biol Trace Elem Res. 2019;189(2):325–335. doi: 10.1007/s12011-018-1474-z.
  • Arredondo M, Núñez MT. Iron and copper metabolism. Mol Aspects Med. 2005;26(4–5):313–327. doi: 10.1016/j.mam.2005.07.010.
  • Toyokuni S. Role of iron in carcinogenesis: cancer as a ferrotoxic disease. Cancer Sci. 2009;100(1):9–16. doi: 10.1111/j.1349-7006.2008.01001.x.
  • Brown RAM, Richardson KL, Kabir TD, et al. Altered iron metabolism and impact in cancer biology, metastasis, and immunology. Front Oncol. 2020;10:476. doi: 10.3389/fonc.2020.00476.
  • Reddy MB, Clark L. Iron, oxidative stress, and disease risk. Nutr Rev. 2004;62(3):120–124. doi: 10.1111/j.1753-4887.2004.tb00033.x.
  • Hsing AW, McLaughlin JK, Olsen JH, et al. Cancer risk following primary hemochromatosis: a population-based cohort study in Denmark. Int J Cancer. 1995;60(2):160–162. doi: 10.1002/ijc.2910600204.
  • Jayachandran A, Shrestha R, Bridle KR, et al. Association between hereditary hemochromatosis and hepatocellular carcinoma: a comprehensive review. HR. 2020;2020(8). doi: 10.20517/2394-5079.2019.35.
  • Sarkar PD, VAS. Analysis of serum trace elements (copper, iron and zinc) level in women with breast cancer. J App Med Sci. 2017;11:4420–4426.
  • Marques O, da Silva BM, Porto G, et al. Iron homeostasis in breast cancer. Cancer Lett. 2014;347(1):1–14. doi: 10.1016/j.canlet.2014.01.029.
  • Daniels TR, Bernabeu E, Rodríguez JA, et al. The transferrin receptor and the targeted delivery of therapeutic agents against cancer. Biochim Biophys Acta. 2012;1820(3):291–317. doi: 10.1016/j.bbagen.2011.07.016.
  • Shen Y, Li X, Zhao B, et al. Iron metabolism gene expression and prognostic features of hepatocellular carcinoma. J Cell Biochem. 2018;119(11):9178–9204. doi: 10.1002/jcb.27184.
  • Duan X, He K, Li J, et al. Tumor associated macrophages deliver iron to tumor cells via Lcn2. Int J Physiol Pathophysiol Pharmacol. 2018;10(2):105–114.
  • Nagababu E, Gulyani S, Earley CJ, et al. Iron-deficiency anaemia enhances red blood cell oxidative stress. Free Radic Res. 2008;42(9):824–829. doi: 10.1080/10715760802459879.
  • Doguer C, Ha JH, Collins JF. Intersection of iron and copper metabolism in the mammalian intestine and liver. Compr Physiol. 2018;8(4):1433–1461. doi: 10.1002/cphy.c170045.
  • Aubert L, Nandagopal N, Steinhart Z, et al. Copper bioavailability is a KRAS-specific vulnerability in colorectal cancer. Nat Commun. 2020;11(1):3701. doi: 10.1038/s41467-020-17549-y.
  • Denoyer D, Masaldan S, La Fontaine S, et al. Targeting copper in cancer therapy: ‘Copper that cancer’. Metallomics. 2015;7(11):1459–1476. doi: 10.1039/c5mt00149h.
  • Saleh SAK, Adly HM, Abdelkhaliq AA, et al. Serum levels of selenium, zinc, copper, manganese, and iron in prostate cancer patients. Curr Urol. 2020;14(1):44–49. doi: 10.1159/000499261.
  • Janbabai G, Alipour A, Ehteshami S, et al. Investigation of trace elements in the hair and nail of patients with stomach cancer. Indian J Clin Biochem. 2018;33(4):450–455. doi: 10.1007/s12291-017-0693-y.
  • Wahab A, Mushtaq K, Khan A, et al. Zinc-induced hypocupremia and pancytopenia, from zinc supplementation to its toxicity, a case report. J Community Hosp Intern Med Perspect. 2021;11(6):843–846. doi: 10.1080/20009666.2021.1983319.
  • Telianidis J, Hung YH, Materia S, et al. Role of the P-type ATPases, ATP7A and ATP7B in brain copper homeostasis. Front Aging Neurosci. 2013;5:44. doi: 10.3389/fnagi.2013.00044.
  • Ojha R, Prasad AN. Menkes disease: what a multidisciplinary approach can do. J Multidiscip Healthc. 2016;9:371–385. doi: 10.2147/jmdh.s93454.
  • Mazdak H, Yazdekhasti F, Movahedian A, et al. The comparative study of serum iron, copper, and zinc levels between bladder cancer patients and a control group. Int Urol Nephrol. 2010;42(1):89–93. doi: 10.1007/s11255-009-9583-4.
  • Bosland MC, Kato I, Zeleniuch-Jacquotte A, et al. Effect of soy protein isolate supplementation on biochemical recurrence of prostate cancer after radical prostatectomy: a randomized TrialSoy protein supplement and prostate cancer RecurrenceSoy protein supplement and prostate cancer recurrence. JAMA. 2013;310(2):170–178. doi: 10.1001/jama.2013.7842.
  • Platz EA, Helzlsouer KJ. Selenium, zinc, and prostate cancer. Epidemiol Rev. 2001;23(1):93–101. doi: 10.1093/oxfordjournals.epirev.a000801.
  • Ressnerova A, Raudenska M, Holubova M, et al. Zinc and copper homeostasis in head and neck cancer: review and meta-analysis. Curr Med Chem. 2016;23(13):1304–1330. doi: 10.2174/0929867323666160405111543.
  • Smith ML, Lancia JK, Mercer TI, et al. Selenium compounds regulate p53 by common and distinctive mechanisms. Anticancer Res. 2004;24(3a):1401–1408.
  • Chasapis CT, Ntoupa PA, Spiliopoulou CA, et al. Recent aspects of the effects of zinc on human health. Arch Toxicol. 2020;94(5):1443–1460. doi: 10.1007/s00204-020-02702-9.
  • Olechnowicz J, Tinkov A, Skalny A, et al. Zinc status is associated with inflammation, oxidative stress, lipid, and glucose metabolism. J Physiol Sci. 2018;68(1):19–31. doi: 10.1007/s12576-017-0571-7.
  • Bai Y, Wang G, Fu W, et al. Circulating essential metals and lung cancer: risk assessment and potential molecular effects. Environ Int. 2019;127:685–693. doi: 10.1016/j.envint.2019.04.021.
  • Juloski JT, Rakic A, Ćuk VV, et al. Colorectal cancer and trace elements alteration. J Trace Elem Med Biol. 2020;59:126451. doi: 10.1016/j.jtemb.2020.126451.
  • Sravani AB, Ghate V, Lewis S. Human papillomavirus infection, cervical cancer and the less explored role of trace elements. Biol Trace Elem Res. 2023;201(3):1026–1050. doi: 10.1007/s12011-022-03226-2.
  • Carlisle AE, Lee N, Matthew-Onabanjo AN, et al. Selenium detoxification is required for cancer-cell survival. Nat Metab. 2020;2(7):603–611. doi: 10.1038/s42255-020-0224-7.
  • Nunziata C, Polo A, Sorice A, et al. Structural analysis of human SEPHS2 protein, a selenocysteine machinery component, over-expressed in triple negative breast cancer. Sci Rep. 2019;9(1):16131. doi: 10.1038/s41598-019-52718-0.
  • Lossow K, Schwarz M, Kipp AP. Are trace element concentrations suitable biomarkers for the diagnosis of cancer? Redox Biol. 2021;42:101900. doi: 10.1016/j.redox.2021.101900.
  • Faber M, Coudray C, Hida H, et al. Lipid peroxidation products, and vitamin and trace element status in patients with cancer before and after chemotherapy, including adriamycin. A preliminary study. Biol Trace Elem Res. 1995;47(1–3):117–123. doi: 10.1007/bf02790108.
  • Joazeiro CA, Weissman AM. RING finger proteins: mediators of ubiquitin ligase activity. Cell. 2000;102(5):549–552. doi: 10.1016/s0092-8674(00)00077-5.
  • Rua RM, Nogales F, Carreras O, et al. Selenium, selenoproteins and cancer of the thyroid. J Trace Elem Med Biol. 2023;76:127115. doi: 10.1016/j.jtemb.2022.127115.
  • Bjelakovic G, Gluud LL, Nikolova D, et al. Meta-analysis: antioxidant supplements for liver diseases – the Cochrane Hepato-Biliary Group. Aliment Pharmacol Ther. 2010;32(3):356–367. doi: 10.1111/j.1365-2036.2010.04371.x.
  • Brinkman M, Buntinx F, Muls E, et al. Use of selenium in chemoprevention of bladder cancer. Lancet Oncol. 2006;7(9):766–774. doi: 10.1016/s1470-2045(06)70862-2.
  • Rayman MP. Selenium in cancer prevention: a review of the evidence and mechanism of action. Proc Nutr Soc. 2005;64(4):527–542. doi: 10.1079/pns2005467.
  • Etminan M, FitzGerald JM, Gleave M, et al. Intake of selenium in the prevention of prostate cancer: a systematic review and meta-analysis. Cancer Causes Control. 2005;16(9):1125–1131. doi: 10.1007/s10552-005-0334-2.
  • Johnson S. The possible crucial role of iron accumulation combined with low tryptophan, zinc and manganese in carcinogenesis. Med Hypotheses. 2001;57(5):539–543. doi: 10.1054/mehy.2001.1361.
  • Chua AC, Morgan EH. Effects of iron deficiency and iron overload on manganese uptake and deposition in the brain and other organs of the rat. Biol Trace Elem Res. 1996;55(1–2):39–54. doi: 10.1007/bf02784167.
  • Pirincci N, Gecit I, Gunes M, et al. Levels of serum trace elements in renal cell carcinoma cases. Asian Pac J Cancer Prev. 2013;14(1):499–502. doi: 10.7314/apjcp.2013.14.1.499.
  • Kasai F, Eshak ES, Tamakoshi A, et al. Dietary manganese intake and risk of liver cancer in Japanese men and women: the JACC study. Nutr Cancer. 2023;75(1):154–163. doi: 10.1080/01635581.2022.2099912.
  • Hunger SP, Mullighan CG. Acute lymphoblastic leukemia in children. N Engl J Med. 2015;373(16):1541–1552. doi: 10.1056/NEJMra1400972.
  • Onciu M. Acute lymphoblastic leukemia. Hematol Oncol Clin North Am. 2009;23(4):655–674. doi: 10.1016/j.hoc.2009.04.009.
  • Sitaresmi MN, Mostert S, Gundy CM, Veerman AJ. Health-related quality of life assessment in indonesian childhood acute lymphoblastic leukemia. Health Qual Life Outcomes. 2008;6(1):96. doi: 10.1186/1477-7525-6-96.
  • Zahnreich S, Schmidberger H. Childhood cancer: occurrence, treatment and risk of second primary malignancies. Cancers. 2021;13(11):2607. doi: 10.3390/cancers13112607.
  • Gm C. The cell: a molecular approach. Sunderland (MA): Sinauer Associates; 2000.
  • Löwenberg B, Downing JR, Burnett A. Acute myeloid leukemia. N Engl J Med. 1999;341(14):1051–1062. doi: 10.1056/nejm199909303411407.
  • Orazi A. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases. Pathobiology. 2007;74(2):97–114. doi: 10.1159/000101709.
  • Lagunas-Rangel FA, Chávez-Valencia V, Gómez-Guijosa M, et al. Acute myeloid leukemia-genetic alterations and their clinical prognosis. Int J Hematol Oncol Stem Cell Res. 2017;11(4):328–339.
  • Zuo XL, Chen JM, Zhou X, et al. Levels of selenium, zinc, copper, and antioxidant enzyme activity in patients with leukemia. Biol Trace Elem Res. 2006;114(1–3):41–53. doi: 10.1385/bter:114:1:41.
  • Dines DE, Elveback LR, McCall JT. Zinc, copper, and iron content of pleural fluid in benign and neoplastic disease. Thorax. 1972;27(3):368–370. doi: 10.1136/thx.27.3.368.
  • Hrgovcic M, Tessmer CF, Mingkler TM, et al. Serum copper levels in lymphoma and leukemia. Special reference to Hodgkin’s disease. Cancer. 1968;21(4):743–755. doi: 10.1002/1097-0142(196804)21:4<743::AID-CNCR2820210427>3.0.CO;2-A.
  • Margerison AC, Mann JR. Serum copper, serum ceruloplasmin, and erythrocyte sedimentation rate measurements in children with Hodgkin’s disease, non-Hodgkin’s lymphoma, and nonmalignant lymphadenopathy. Cancer. 1985;55(7):1501–1506. doi: 10.1002/1097-0142(19850401)55:7<1501::aid-cncr2820550714>3.0.co;2-k.
  • Schwartz MK. Role of trace elements in cancer. Cancer Res. 1975;35(11 Pt. 2):3481–3487.
  • Sunderman FWJr., Trudeau EAJr., Horak E, et al. Serum ceruloplasmin concentrations in rats with primary and transplanted sarcomas induced by nickel subsulfide. Ann Clin Lab Sci. 1979;9(1):60–67.
  • O’Regan S, Carson S, Chesney RW, et al. Electrolyte and acid-base disturbances in the management of leukemia. Blood. 1977;49(3):345–353. doi: 10.1182/blood.V49.3.345.345.
  • Wang J, Huang P, Lang C, et al. The progress in the relationship between trace elements and acute lymphoblastic leukemia. Front Cell Dev Biol. 2023;11:1145563. doi: 10.3389/fcell.2023.1145563.
  • Dafaalla AA, Elshaygi EAA. Assessment of serum level of electrolytes and trace elements in leukaemia patients in Sudan. J Sci Technol. 2017;18:136–141.
  • Schafer AL, Shoback DM. Hypocalcemia: diagnosis and treatment. In Feingold KR, Anawalt B, Blackman MR, et al., editors. Endotext. South Dartmouth (MA): MDText.com, Inc.; 2000.
  • Ankar A, Kumar A. Vitamin B12 deficiency. In: StatPearls. Treasure island (FL): StatPearls publishing; 2022.
  • Beguin Y, Brasseur F, Weber G, et al. Observations of serum trace elements in chronic lymphocytic leukemia. Cancer. 1987;60(8):1842–1846. doi: 10.1002/1097-0142(19871015)60:8<1842::aid-cncr2820600828>3.0.co;2-w.
  • Khuder A, Bakir M, Solaiman A, et al. Major, minor, and trace elements in whole blood of patients with different leukemia patterns. Nukleonika. 2012;57:389–399.
  • Atieh Modaressi MH, Shamshiri AR, Mandar R, et al. Trace elements (Se, Zn, and Cu) levels in patients with newly diagnosed acute leukemia. Int J Hematol Oncol Stem Cell Res. 2015;6(4):5–10.
  • Zekavat OR, Karimi M, Majidi F, et al. Trace elements in children with acute lymphoblastic leukemia. Asian Pac J Cancer Prev. 2021;22(S1):43–47. doi: 10.31557/apjcp.2021.22.s1.43.
  • Elradi MMM. Investigation of selected trace elements in Sudanese patients with leukemia using NAA; 2010. Available from INIS in electronic form. Also available from Sudan Atomic Energy Commission, Khartoum (SD). Available from: http://inis.iaea.org/search/search.aspx?orig_q=RN:42088893
  • Canellas CG, Carvalho SM, De Jesus EF, et al. Trace and major elements in serum of patients with chronic myelogenous leukemia. J Radioanal Nucl Chem. 2006;269(3):631–634. doi: 10.1007/s10967-006-0276-5.
  • Valadbeigi S, Javadian S, Ebrahimi-Rad M, et al. Assessment of trace elements in serum of acute lymphoblastic and myeloid leukemia patients. Exp Oncol. 2023;41(1):69–71. doi: 10.32471/exp-oncology.2312-8852.vol-41-no-1.12730.
  • Lelièvre P, Sancey L, Coll JL, et al. The multifaceted roles of copper in cancer: a trace metal element with dysregulated metabolism, but also a target or a bullet for therapy. Cancers. 2020;12(12):3594. doi: 10.3390/cancers12123594.
  • Darbre PD. Metalloestrogens: an emerging class of inorganic xenoestrogens with potential to add to the oestrogenic burden of the human breast. J Appl Toxicol. 2006;26(3):191–197. doi: 10.1002/jat.1135.
  • Cabré N, Luciano-Mateo F, Arenas M, et al. Trace element concentrations in breast cancer patients. Breast. 2018;42:142–149. doi: 10.1016/j.breast.2018.09.005.
  • Aaltonen LM, Rautiainen N, Sellman J, et al. Voice quality after treatment of early vocal cord cancer: a randomized trial comparing laser surgery with radiation therapy. Int J Radiat Oncol Biol Phys. 2014;90(2):255–260. doi: 10.1016/j.ijrobp.2014.06.032.
  • Sanchez-Barcelo EJ, Mediavilla MD, Alonso-Gonzalez C, et al. Melatonin uses in oncology: breast cancer prevention and reduction of the side effects of chemotherapy and radiation. Expert Opin Investig Drugs. 2012;21(6):819–831. doi: 10.1517/13543784.2012.681045.
  • van der Lely AJ, Hutson RK, Trainer PJ, et al. Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist. Lancet. 2001;358(9295):1754–1759. doi: 10.1016/s0140-6736(01)06844-1.
  • Wei J, Meng L, Hou X, et al. Radiation-induced skin reactions: mechanism and treatment. Cancer Manag Res. 2019;11:167–177. doi: 10.2147/cmar.s188655.
  • Choi R, Kim MJ, Sohn I, et al. Serum trace elements and their associations with breast cancer subgroups in Korean breast cancer patients. Nutrients. 2018;11(1):37. doi: 10.3390/nu11010037.
  • Kuo HW, Chen SF, Wu CC, et al. Serum and tissue trace elements in patients with breast cancer in Taiwan. Biol Trace Elem Res. 2002;89(1):1–11. doi: 10.1385/bter:89:1:1.
  • Cai X, Wang C, Yu W, et al. Selenium exposure and cancer risk: an updated meta-analysis and meta-regression. Sci Rep. 2016;6(1):19213. doi: 10.1038/srep19213.
  • Jablonska E, Socha K, Reszka E, et al. Cadmium, arsenic, selenium and iron–implications for tumor progression in breast cancer. Environ Toxicol Pharmacol. 2017;53:151–157. doi: 10.1016/j.etap.2017.05.014.
  • Adeoti ML, Oguntola AS, Akanni EO, et al. Trace elements; copper, zinc and selenium, in breast cancer afflicted female patients in LAUTECH Osogbo, Nigeria. Indian J Cancer. 2015;52(1):106–109. doi: 10.4103/0019-509x.175573.
  • Shukla S, Gupta S. Dietary agents in the chemoprevention of prostate cancer. Nutr Cancer. 2005;53(1):18–32. doi: 10.1207/s15327914nc5301_3.
  • Larner F, Woodley LN, Shousha S, et al. Zinc isotopic compositions of breast cancer tissue. Metallomics. 2015;7(1):112–117. doi: 10.1039/c4mt00260a.
  • Riesop D, Hirner AV, Rusch P, et al. Zinc distribution within breast cancer tissue: a possible marker for histological grading? J Cancer Res Clin Oncol. 2015;141(7):1321–1331. doi: 10.1007/s00432-015-1932-3.
  • Silva MP, Soave DF, Ribeiro-Silva A, et al. Trace elements as tumor biomarkers and prognostic factors in breast cancer: a study through energy dispersive X-ray fluorescence. BMC Res Notes. 2012;5(1):194. doi: 10.1186/1756-0500-5-194.
  • Tian Z, Li J, Zhang Z, et al. Highly sensitive and robust peroxidase-like activity of porous nanorods of ceria and their application for breast cancer detection. Biomaterials. 2015;59:116–124. doi: 10.1016/j.biomaterials.2015.04.039.
  • Baker R, Rogers KD, Shepherd N, et al. New relationships between breast microcalcifications and cancer. Br J Cancer. 2010;103(7):1034–1039. doi: 10.1038/sj.bjc.6605873.
  • Haka AS, Shafer-Peltier KE, Fitzmaurice M, et al. Identifying microcalcifications in benign and malignant breast lesions by probing differences in their chemical composition using Raman spectroscopy. Cancer Res. 2002;62(18):5375–5380.
  • Morgan MP, Cooke MM, McCarthy GM. Microcalcifications associated with breast cancer: an epiphenomenon or biologically significant feature of selected tumors? J Mammary Gland Biol Neoplasia. 2005;10(2):181–187. doi: 10.1007/s10911-005-5400-6.
  • Fischer Walker C, Black RE. Zinc and the risk for infectious disease. Annu Rev Nutr. 2004;24(1):255–275. doi: 10.1146/annurev.nutr.23.011702.073054.
  • Jin G, Cao H, Qiao Y, et al. Osteogenic activity and antibacterial effect of zinc ion implanted titanium. Colloids Surf B Biointerfaces. 2014;117:158–165. doi: 10.1016/j.colsurfb.2014.02.025.
  • O’Connor JP, Kanjilal D, Teitelbaum M, et al. Zinc as a therapeutic agent in bone regeneration. Materials. 2020;13(10):2211. doi: 10.3390/ma13102211.
  • Prasad AS, Beck FW, Snell DC, et al. Zinc in cancer prevention. Nutr Cancer. 2009;61(6):879–887. doi: 10.1080/01635580903285122.
  • Zhang Y, Zhao W, Zhang HJ, et al. Overexpression of copper zinc superoxide dismutase suppresses human glioma cell growth. Cancer Res. 2002;62(4):1205–1212.
  • Plum LM, Rink L, Haase H. The essential toxin: impact of zinc on human health. Int J Environ Res Public Health. 2010;7(4):1342–1365. doi: 10.3390/ijerph7041342.
  • Franklin RB, Costello LC. Zinc as an anti-tumor agent in prostate cancer and in other cancers. Arch Biochem Biophys. 2007;463(2):211–217. doi: 10.1016/j.abb.2007.02.033.
  • Clavijo Jordan MV, Lo ST, Chen S, et al. Zinc-sensitive MRI contrast agent detects differential release of Zn(II) ions from the healthy vs. malignant mouse prostate. Proc Natl Acad Sci USA. 2016;113(37):E5464–E5471. doi: 10.1073/pnas.1609450113.
  • Ishii K, Otsuka T, Iguchi K, et al. Evidence that the prostate-specific antigen (PSA)/Zn2+ axis may play a role in human prostate cancer cell invasion. Cancer Lett. 2004;207(1):79–87. doi: 10.1016/j.canlet.2003.09.029.
  • Gumulec J, Masarik M, Krizkova S, et al. Insight to physiology and pathology of zinc(II) ions and their actions in breast and prostate carcinoma. Curr Med Chem. 2011;18(33):5041–5051. doi: 10.2174/092986711797636126.
  • Saleh SAK, Adly HM, Abdulkhaliq A, et al. Correlation of some trace elements serum levels with prostate cancer progression in Saudi patients. TOPHJ. 2019;12(1):212–218. doi: 10.2174/1874944501912010212.
  • Feki-Tounsi M, Olmedo P, Gil F, et al. Cadmium in blood of Tunisian men and risk of bladder cancer: interactions with arsenic exposure and smoking. Environ Sci Pollut Res Int. 2013;20(10):7204–7213. doi: 10.1007/s11356-013-1716-8.
  • Ganiyu AO, Mabel CD. The serum levels of trace metals in Nigerian males with different PSA values. Malays J Med Sci. 2008;15(2):39–42.
  • Järup L, Akesson A. Current status of cadmium as an environmental health problem. Toxicol Appl Pharmacol. 2009;238(3):201–208. doi: 10.1016/j.taap.2009.04.020.
  • Rafati Rahimzadeh M, Rafati Rahimzadeh M, Kazemi S, et al. Cadmium toxicity and treatment: an update. Caspian J Intern Med. 2017;8(3):135–145. doi: 10.22088/cjim.8.3.135.
  • Waalkes MP. Cadmium carcinogenesis in review. J Inorg Biochem. 2000;79(1–4):241–244. doi: 10.1016/s0162-0134(00)00009-x.
  • Fang MZ, Mar W, Cho MH. Cadmium affects genes involved in growth regulation during two-stage transformation of Balb/3T3 cells. Toxicology. 2002;177(2–3):253–265. doi: 10.1016/s0300-483x(02)00229-9.
  • Aggarwal V, Tuli HS, Varol A, et al. Role of reactive oxygen species in cancer progression: molecular mechanisms and recent advancements. Biomolecules. 2019;9(11):735. doi: 10.3390/biom9110735.
  • Qayyum MA, Shah MH. Comparative study of trace elements in blood, scalp hair and nails of prostate cancer patients in relation to healthy donors. Biol Trace Elem Res. 2014;162(1–3):46–57. doi: 10.1007/s12011-014-0123-4.
  • Rapisarda V, Miozzi E, Loreto C, et al. Cadmium exposure and prostate cancer: insights, mechanisms and perspectives. Front Biosci. 2018;23(9):1687–1700. doi: 10.2741/4667.
  • Bede-Ojimadu O, Nnamah N, Onuegbu J, et al. Cadmium exposure and the risk of prostate cancer among Nigerian men: effect modification by zinc status. J Trace Elem Med Biol. 2023;78:127168. doi: 10.1016/j.jtemb.2023.127168.
  • Denoyer D, Pearson HB, Clatworthy SA, et al. Copper as a target for prostate cancer therapeutics: copper-ionophore pharmacology and altering systemic copper distribution. Oncotarget. 2016;7(24):37064–37080. doi: 10.18632/oncotarget.9245.
  • Osredkar J. Copper and zinc, biological role and significance of copper/zinc imbalance. J Clin Toxicol. 2011;S3(1). doi: 10.4172/2161-0495.S3-001.
  • Safi R, Nelson ER, Chitneni SK, et al. Copper signaling axis as a target for prostate cancer therapeutics. Cancer Res. 2014;74(20):5819–5831. doi: 10.1158/0008-5472.can-13-3527.
  • Valko M, Jomova K, Rhodes CJ, et al. Redox- and non-redox-metal-induced formation of free radicals and their role in human disease. Arch Toxicol. 2016;90(1):1–37. doi: 10.1007/s00204-015-1579-5.
  • Kim YS, Milner J. Molecular targets for selenium in cancer prevention. Nutr Cancer. 2001;40(1):50–54. doi: 10.1207/s15327914nc401_10.
  • Seng H-L, Tiekink ERT. Anti-cancer potential of selenium- and tellurium-containing species: opportunities abound! Applied Organom Chemis. 2012;26(12):655–662. doi: 10.1002/aoc.2928.
  • Short SP, Pilat JM, Williams CS. Roles for selenium and selenoprotein P in the development, progression, and prevention of intestinal disease. Free Radic Biol Med. 2018;127:26–35. doi: 10.1016/j.freeradbiomed.2018.05.066.
  • Duffield-Lillico AJ, Dalkin BL, Reid ME, et al. Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: an analysis of the complete treatment period of the nutritional prevention of cancer trial. BJU Int. 2003;91(7):608–612. doi: 10.1046/j.1464-410x.2003.04167.x.
  • Jacobs ET, Jiang R, Alberts DS, et al. Selenium and colorectal adenoma: results of a pooled analysis. J Natl Cancer Inst. 2004;96(22):1669–1675. doi: 10.1093/jnci/djh310.
  • Hosnedlova B, Kepinska M, Skalickova S, et al. A summary of new findings on the biological effects of selenium in selected animal species–a critical review. Int J Mol Sci. 2017;18(10):2209. doi: 10.3390/ijms18102209.
  • Raymond LJ, Deth RC, Ralston NV. Potential role of selenoenzymes and antioxidant metabolism in relation to autism etiology and pathology. Autism Res Treat. 2014;2014:164938. doi: 10.1155/2014/164938.
  • Zeng H. Selenium as an essential micronutrient: roles in cell cycle and apoptosis. Molecules. 2009;14(3):1263–1278. doi: 10.3390/molecules14031263.
  • Zaichick S, Zaichick V, Nosenko S, et al. Mass fractions of 52 trace elements and zinc/trace element content ratios in intact human prostates investigated by inductively coupled plasma mass spectrometry. Biol Trace Elem Res. 2012;149(2):171–183. doi: 10.1007/s12011-012-9427-4.
  • Zaichick V, Zaichick S. Ratios of Rb/trace elements as prostate cancer markers. Can Res Clin Oncol. 2017;1:30–41.
  • Karimi G, Shahar S, Homayouni N, et al. Association between trace element and heavy metal levels in hair and nail with prostate cancer. Asian Pac J Cancer Prev. 2012;13(9):4249–4253. doi: 10.7314/apjcp.2012.13.9.4249.
  • Skrajnowska D, Jagielska A, Ruszczyńska A, et al. Title changes in the mineral composition of rat femoral bones induced by implantation of LNCaP prostate cancer cells and dietary supplementation. Nutrients. 2020;13(1):100. doi: 10.3390/nu13010100.
  • Leftin A, Zhao H, Turkekul M, et al. Iron deposition is associated with differential macrophage infiltration and therapeutic response to iron chelation in prostate cancer. Sci Rep. 2017;7(1):11632. doi: 10.1038/s41598-017-11899-2.
  • Tesfay L, Clausen KA, Kim JW, et al. Hepcidin regulation in prostate and its disruption in prostate cancer. Cancer Res. 2015;75(11):2254–2263. doi: 10.1158/0008-5472.can-14-2465.
  • Vela D. Iron metabolism in prostate cancer; from basic science to new therapeutic strategies. Front Oncol. 2018;8:547. doi: 10.3389/fonc.2018.00547.
  • Wolk A. Diet, lifestyle and risk of prostate cancer. Acta Oncol. 2005;44(3):277–281. doi: 10.1080/02841860510029572.
  • Singh CK, Malas KM, Tydrick C, et al. Analysis of zinc-exporters expression in prostate cancer. Sci Rep. 2016;6:36772.doi: 10.1038/srep36772.
  • Jian L, Xie LP, Lee AH, et al. Protective effect of green tea against prostate cancer: a case-control study in southeast China. Int J Cancer. 2004;108(1):130–135. doi: 10.1002/ijc.11550.
  • Outzen M, Tjønneland A, Larsen EH, et al. Selenium status and risk of prostate cancer in a Danish population. Br J Nutr. 2016;115(9):1669–1677. doi: 10.1017/s0007114516000726.
  • Lajunen LH, Perämäki P. Spectrochemical analysis by atomic absorption and emission. London: Royal Society of Chemistry; 2004.
  • Sanz-Medel A, Pereiro R. Atomic absorption spectrometry: an introduction. New York: Momentum Press, LLC; 2014.
  • Oshina I, Spigulis J. Beer-Lambert law for optical tissue diagnostics: current state of the art and the main limitations. J Biomed Opt. 2021;26(10). doi: 10.1117/1.jbo.26.10.100901.
  • Zettner A. Principles and applications of atomic absorption spectroscopy. Adv Clin Chem. 1964;7:1–62. doi: 10.1016/s0065-2423(08)60372-8.
  • Iwata Y. Particle induced X-ray emission (PIXE) for analysis of trace elements in biological materials. Nihon Rinsho. 1996;54(1):221–227.
  • Lahiry S, Khanra S, Kumar R, et al. Particle induced X-ray emission study of blood samples of Indian kala-azar patients. J Parasit Dis. 2017;41(1):193–198. doi: 10.1007/s12639-016-0775-4.
  • Maenhaut W. Multielement analysis of biological materials by particle-induced X-ray emission (PIXE). Scanning Microsc. 1990;4(1):43–59; discussion 59–62.
  • Mirani F, Maffini A, Casamichiela F, et al. Integrated quantitative PIXE analysis and EDX spectroscopy using a laser-driven particle source. Sci Adv. 2021;7(3):1–11. doi: 10.1126/sciadv.abc8660.
  • Mulware SJ. Comparative trace elemental analysis in cancerous and noncancerous human tissues using PIXE. J Biophys. 2013;2013:192026–192028. doi: 10.1155/2013/192026.
  • Mulware SJ. The review of nuclear microscopy techniques: an approach for nondestructive trace elemental analysis and mapping of biological materials. J Biophys. 2015;2015:740751–740757. doi: 10.1155/2015/740751.
  • Denkhaus E, Salnikow K. Nickel essentiality, toxicity, and carcinogenicity. Crit Rev Oncol Hematol. 2002;42(1):35–56. doi: 10.1016/s1040-8428(01)00214-1.
  • Armendariz AD, Vulpe CD. Nutritional and genetic copper overload in a mouse fibroblast cell line. J Nutr. 2003;133:203E-82E.
  • Patstone G, Maher P. Copper and calcium binding motifs in the extracellular domains of fibroblast growth factor receptors. J Biol Chem. 1996;271(7):3343–3346. doi: 10.1074/jbc.271.7.3343.
  • Geraki K, Farquharson MJ, Bradley DA. Concentrations of Fe, Cu and Zn in breast tissue: a synchrotron XRF study. Phys Med Biol. 2002;47(13):2327–2339. doi: 10.1088/0031-9155/47/13/310.
  • Cunzhi HAN, Jiexian J, Xianwen Z, et al. Serum and tissue levels of six trace elements and copper/zinc ratio in patients with cervical cancer and uterine myoma. Biol Trace Elem Res. 2003;94(2):113–122. doi: 10.1385/BTER:94:2:113.
  • Kucharzewski M, Braziewicz J, Majewska U, et al. Selenium, copper, and zinc concentrations in intestinal cancer tissue and in Colon and rectum polyps. Biol Trace Elem Res. 2003;92(1):1–10. doi: 10.1385/BTER:92:1:1.
  • Rink L, Gabriel P. Zinc and the immune system. Proc Nutr Soc. 2000;59(4):541–552. doi: 10.1017/s0029665100000781.
  • Fraker PJ, King LE, Laakko T, et al. The dynamic link between the integrity of the immune system and zinc status. J Nutr. 2000;130(5S Suppl):1399S–1406S. doi: 10.1093/jn/130.5.1399S.
  • Zaichick VYe,Sviridova TV, Zaichick SV. Zinc in the human prostate gland: normal, hyperplastic and cancerous. Int Urol Nephrol. 1997;29(5):565–574. doi: 10.1007/BF02552202.
  • Iguchi K, Hamatake M, Ishida R, et al. Induction of necrosis by zinc in prostate carcinoma cells and identification of proteins increased in association with this induction. Eur J Biochem. 1998;253(3):766–770. doi: 10.1046/j.1432-1327.1998.2530766.x.
  • Ishii K, Usui S, Sugimura Y, et al. Inhibition of aminopeptidase N (AP-N) and urokinase-type plasminogen activator (uPA) by zinc suppresses the invasion activity in human urological cancer cells. Biol Pharm Bull. 2001;24(3):226–230. doi: 10.1248/bpb.24.226.
  • Ishii K, Usui S, Sugimura Y, et al. Aminopeptidase N regulated by zinc in human prostate participates in tumor cell invasion. Int J Cancer. 2001;92(1):49–54. doi: 10.1002/1097-0215(200102)9999:9999<::AID-IJC1161>3.0.CO;2-S.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.